Norcantharidin ameliorates estrogen deficient-mediated bone loss by attenuating the activation of extracellular signal-regulated kinase/ROS/NLRP3 inflammasome signaling.
Norcantharidin ameliorates estrogen deficient-mediated bone loss by attenuating the activation of extracellular signal-regulated kinase/ROS/NLRP3 inflammasome signaling.
复制标题
DOI:
10.3389/fphar.2022.1019478
复制
发表时间:
2022
影响因子:
5.6
通讯作者:
中科院分区:
文献类型:
--
作者:
Osteoporosis, characterized by reduced bone mass, aberrant bone architecture, and elevated bone fragility, is driven by a disruption of bone homeostasis between bone resorption and bone formation. However, up to now, no drugs are perfect for osteoporosis treatment due to different defects. In this study, we demonstrated that norcantharidin (NCTD) could inhibit osteoclast formation and bone resorption by attenuating the ERK, ROS and NLRP3 inflammasomes pathways in vitro. Moreover, our in vivo study further confirms its preventive effects on estrogen-deficiency bone loss by inhibiting osteoclast formation and functions. Therefore, we could conclude that NCTD might be a potential candidates for the prevention and treatment of osteoporosis.
登录
查看更多内容
影响因子:
4.6
作者:
Peng C;Li Z;Niu Z;Niu W;Xu Z;Gao H;Niu W;Wang J;He Z;Gao C;Lin P;Agrez M;Zhang Z;Niu J
通讯作者:
Niu J
影响因子:
5.6
作者:
Chen K;Lv ZT;Cheng P;Zhu WT;Liang S;Yang Q;Parkman VA;Zhou CH;Jing XZ;Liu H;Wang YT;Lin H;Liao H;Chen AM
通讯作者:
Chen AM
DOI:
10.1002/jbmr.2269
发表时间:
2014-11
期刊:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
影响因子:
--
作者:
Wright NC;Looker AC;Saag KG;Curtis JR;Delzell ES;Randall S;Dawson-Hughes B
通讯作者:
Dawson-Hughes B
影响因子:
6.2
作者:
Ivaska, Kaisa K.;Gerdhem, Paul;Obrant, Karl J.
通讯作者:
Obrant, Karl J.
影响因子:
6.2
作者:
Burge, Russel;Dawson-Hughes, Bess;Tosteson, Anna
通讯作者:
Tosteson, Anna